Evidence map›Paper›PMID 39436654›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Cross-chiral exponential amplification of an RNA enzyme.

Wesley G Cochrane, Grant A L Bare, Gerald F Joyce, David P Horning

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Cross-chiral exponential amplification of an RNA enzyme.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wesley G Cochrane *The Salk Institute, La Jolla, CA 92037.ORCID 0000-0002-3325-6921
Grant A L Bare *The Salk Institute, La Jolla, CA 92037.ORCID 0000-0003-3446-1633
Gerald F JoyceThe Salk Institute, La Jolla, CA 92037.ORCID 0000-0003-0603-2874
David P HorningThe Salk Institute, La Jolla, CA 92037.ORCID 0000-0003-3357-6092

Funding

BD FACSAria Fusion for Flow Cytometry Core FacilityS10OD023689 · OD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI ZHENG, YE · 2018 to 2018
$530k
Accelerated evolution of biological RNAsF32GM146435 · NIGMS · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI COCHRANE, WESLEY GARRET · 2022 to 2023
$139k
HHS | NIH | National Institute of General Medical Sciences (NIGMS) F32GM146435NIGMS NIH HHS F32 GM146435NIH HHS S10 OD023689NSF (NSF) MCB2114588
6 · The paper itself

Abstract

An RNA ligase ribozyme that catalyzes the joining of RNA molecules of the opposite chiral handedness was optimized for the ability to synthesize its own enantiomer from two component fragments. The mirror-image D- and L-ligases operate in concert to provide a system for cross-chiral replication, whereby they catalyze each other's synthesis and undergo mutual amplification at constant temperature, with apparent exponential growth and a doubling time of about 1 h. Neither the D- nor the L-RNA components alone can achieve autocatalytic self-replication. Cross-chiral exponential amplification can be continued indefinitely through a serial-transfer process that provides an ongoing supply of the component D- and L-substrates. Unlike the familiar paradigm of semiconservative nucleic acid replication that relies on Watson-Crick pairing between complementary strands, cross-chiral replication relies on tertiary interactions between structured nucleic acids "across the mirror." There are few examples, outside of biology, of autocatalytic self-replication systems that undergo exponential amplification and there are no prior examples, in either biological or chemical systems, of cross-chiral replication enabling exponential amplification.

Indexed as

RNA, CatalyticNucleic Acid ConformationRNARNA Ligase (ATP)StereoisomerismRNARNA, CatalyticRNA Ligase (ATP)chiralitydirected evolutionribozymeRNA ligaseRNA replication

Identifiers

PMID39436654
PMCPMC11536142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.